• Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

The Syngene Advantage: Accelerating Progress Through Integrated Technology Transfer

At Syngene, technology transfer is a seamless, cross-site collaboration, accelerating your journey from concept to commercialization. This video showcases the synergy between our Bangalore (BSEZ) and Mangalore (MSEZ) campuses, driven by robust systems and deep expertise. Our facilities are built for uncompromising quality, proudly GMP certified, 21 CFR compliant, and USFDA approved, ensuring global standards are met at every step. From advanced process and analytical research to meticulous engineering and safety protocols, we emphasize alignment, transparency, and cost-effective execution. Discover how Syngene’s commitment to scalable, economical, and safe processes, supported by our dedicated teams, translates into reliable outcomes. Partner with us for long-term manufacturing and supply solutions, backed by scientific alignment and operational synergy that truly puts science to work for your success.

Author

Latest Blogs

Solving Prep-HPLC Challenges in Early Drug Discovery: Efficient Purification of Unstable Prodrugs via C18 SPE

From Fragile to Agile: Strategic imperatives for strengthening biopharma supply chains

Overcoming ADME Challenges in PROTAC Development: Key Insights from Syngene Experts

Bridging the Unbridgeable: The Promise of PROTACs in Drug Discovery

Paws, Pills and Progress – CRDMO’s pivotal role

Reducing variability in gene expression: Bottlenecks and Solutions

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details